An Open Label, Phase II Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Cancers Hoosier Cancer Research Network BRE17-141
NCT04886531 · RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by Ruth Oregan. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Ruth Oregan.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Ruth Oregan currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Ruth Oregan conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Ruth Oregan currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.